Results for tag: "Cellcept"

Cellcept is an immunosuppressive drug used to prevent organ rejection in transplant patients. It is a mycophenolate mofetil (MMF) prodrug, which is converted to its active form, mycophenolic acid (MPA), in the body. Cellcept is used in combination with other immunosuppressants, such as corticosteroids and calcineurin inhibitors, to prevent organ rejection in patients who have received a kidney, heart, or liver transplant. It is also used to treat autoimmune diseases such as lupus and rheumatoid arthritis. Cellcept is a widely used immunosuppressant, and is available in both oral and intravenous formulations. It is generally well tolerated, with the most common side effects being gastrointestinal upset, headache, and skin rash. Cellcept is marketed by several pharmaceutical companies, including Genentech, Novartis, and Mylan. It is also available as a generic drug from several generic manufacturers. Show Less Read more